Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelling”
Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).
ClinicalTrials.gov study NCT00211328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment:an Open-label, Randomized, Contro
ClinicalTrials.gov study NCT06946849. IPD Sharing: NO. Countries: 1. Publications: 0.
UARK 2014-08 A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered Trametinib
ClinicalTrials.gov study NCT02140840. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Analysis of Oral Etoposide Combined With Anlotinib and Envafolimab in First-line Treatment of Elderly Patients With Small Cell Lung Cancer/ Open-label, Single-arm, Exploratory Phas
ClinicalTrials.gov study NCT05685550. IPD Sharing: NO. Countries: 1. Publications: 0.
Relationship Between Adverse Drug Reactions and Unlicensed/ Off-label Drug Use in Hospitalized Children
ClinicalTrials.gov study NCT02852590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07053020. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors
ClinicalTrials.gov study NCT00400023. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis
ClinicalTrials.gov study NCT00825942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia
ClinicalTrials.gov study NCT07393373. IPD Sharing: NO. Countries: 10. Publications: 0.
SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
ClinicalTrials.gov study NCT07141329. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder
ClinicalTrials.gov study NCT02258828. IPD Sharing: YES. Countries: 1. Publications: 0.
Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)
ClinicalTrials.gov study NCT04535999. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115
ClinicalTrials.gov study NCT02185014. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS
ClinicalTrials.gov study NCT03520517. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy
ClinicalTrials.gov study NCT05055024. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions
ClinicalTrials.gov study NCT06671405. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)
ClinicalTrials.gov study NCT01002222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure
ClinicalTrials.gov study NCT00813202. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
ClinicalTrials.gov study NCT00726011. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
ClinicalTrials.gov study NCT05248659. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.